Found 6 matching trials
A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers
PHASE3Dengue fever is caused by an infection with the dengue virus. Vaccination w...
Location
Clinica de la Costa Ltda
Immunogenicity of an Intradermal Qdenga Vaccine Among Healthy Volunteers
EARLY_PHASE1Official title: Immunogenicity of an intradermal Qdenga vaccine among healt...
Location
Faculty of Medicine, Prince of Songkla University
Characterisation of Dengue Vaccine-induced Specific Immunity in Vaccinees With and Without Prior Exposure to Flavivirus Infections or Vaccination
N/AThe goal of this observational study is to learn about the immunity induced...
Location
IRCCS Sacro Cuore Don Calabria
Passive Safety Surveillance Data of Dengue Vaccine, Qdenga (TAK 003) in Private Vaccination Sites in Buenos Aires, Argentina.
N/AThe TAK-003 vaccine, Qdenga, developed by Takeda, was approved by ANMAT in ...
Status
Active Not Recruiting
Location
Fundación Vacunar
A Study to Monitor the Adverse Events of QDENGA Vaccine in Participants in Malaysia
N/AThe main aim of this study is to collect the number and type of medical pro...
Status
Active Not Recruiting
Location
Universiti Malaya
Demographic Characteristics of TAK-003 Dengue Vaccine Recipients in Vietnam
N/AThe study aims to retrospectively describe the demographic characteristics,...
Status
Active Not Recruiting
Location
Vietnam Vaccine Joint Stock Company